BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31523198)

  • 21. Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.
    Best MG; Sol N; In 't Veld SGJG; Vancura A; Muller M; Niemeijer AN; Fejes AV; Tjon Kon Fat LA; Huis In 't Veld AE; Leurs C; Le Large TY; Meijer LL; Kooi IE; Rustenburg F; Schellen P; Verschueren H; Post E; Wedekind LE; Bracht J; Esenkbrink M; Wils L; Favaro F; Schoonhoven JD; Tannous J; Meijers-Heijboer H; Kazemier G; Giovannetti E; Reijneveld JC; Idema S; Killestein J; Heger M; de Jager SC; Urbanus RT; Hoefer IE; Pasterkamp G; Mannhalter C; Gomez-Arroyo J; Bogaard HJ; Noske DP; Vandertop WP; van den Broek D; Ylstra B; Nilsson RJA; Wesseling P; Karachaliou N; Rosell R; Lee-Lewandrowski E; Lewandrowski KB; Tannous BA; de Langen AJ; Smit EF; van den Heuvel MM; Wurdinger T
    Cancer Cell; 2017 Aug; 32(2):238-252.e9. PubMed ID: 28810146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subunit-specific mass spectrometry method identifies haptoglobin subunit alpha as a diagnostic marker in non-small cell lung cancer.
    Park J; Yang JS; Jung G; Woo HI; Park HD; Kim JW; Huh W; Ko JW; Kim H; Cho JY; Lee SY
    J Proteomics; 2013 Dec; 94():302-10. PubMed ID: 24120528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer.
    Yuan K; Chen Z; Li W; Gao CE; Li G; Guo G; Yang Y; Ai Y; Wu L; Zhang M
    Arch Med Res; 2015 Nov; 46(8):635-41. PubMed ID: 26656665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A promising role of interferon regulatory factor 5 as an early warning biomarker for the development of human non-small cell lung cancer.
    Guo J; Wang X; Wang Y; Wang L; Hua S
    Lung Cancer; 2019 Sep; 135():47-55. PubMed ID: 31447002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of telomerase activity and some tumor markers in non-small cell lung cancer.
    Hashim M; Sayed M; Samy N; Elshazly S
    Med Oncol; 2011 Mar; 28(1):322-30. PubMed ID: 20146105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
    Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
    Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas.
    Yu H; Xu Q; Liu F; Ye X; Wang J; Meng X
    J Thorac Oncol; 2015 Apr; 10(4):645-54. PubMed ID: 25590602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
    Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
    Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA sequencing enables systematic identification of platelet transcriptomic alterations in NSCLC patients.
    Zhang Q; Hu H; Liu H; Jin J; Zhu P; Wang S; Shen K; Hu Y; Li Z; Zhan P; Zhu S; Fan H; Zhang J; Lv T; Song Y
    Biomed Pharmacother; 2018 Sep; 105():204-214. PubMed ID: 29857300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.
    Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S
    Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Three Circular RNA Cargoes in Serum Exosomes as Diagnostic Biomarkers of Non-Small-Cell Lung Cancer in the Chinese Population.
    Xian J; Su W; Liu L; Rao B; Lin M; Feng Y; Qiu F; Chen J; Zhou Q; Zhao Z; Lu J; Yang L
    J Mol Diagn; 2020 Aug; 22(8):1096-1108. PubMed ID: 32535085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TEP RNA: a new frontier for early diagnosis of NSCLC.
    Wang Y; Dong A; Jin M; Li S; Duan Y
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):97. PubMed ID: 38372784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer.
    Lafuente-Sanchis A; Zúñiga Á; Galbis JM; Cremades A; Estors M; Martínez-Hernández NJ; Carretero J
    Clin Transl Oncol; 2016 Aug; 18(8):798-804. PubMed ID: 26542178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
    Cui Y; Wang W; Yao S; Qiu Z; Cong L
    J Cancer Res Ther; 2020; 16(7):1641-1647. PubMed ID: 33565511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
    Trakunram K; Chaniad P; Geater SL; Keeratichananont W; Chittithavorn V; Uttayamakul S; Buya S; Raungrut P; Thongsuksai P
    Cancer Biol Med; 2020 Aug; 17(3):652-663. PubMed ID: 32944397
    [No Abstract]   [Full Text] [Related]  

  • 37. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
    Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
    J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
    Tantai J; Hu D; Yang Y; Geng J
    Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P-selectin-mediated platelet activation promotes adhesion of non-small cell lung carcinoma cells on vascular endothelial cells under flow.
    Gong L; Mi HJ; Zhu H; Zhou X; Yang H
    Mol Med Rep; 2012 Apr; 5(4):935-42. PubMed ID: 22266541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.